Last updated: 31 July 2024 at 7:03pm EST

Nancy A. Grygiel Net Worth




The estimated Net Worth of Nancy A. Grygiel is at least $4.66 millió dollars as of 3 May 2024. Ms Grygiel owns over 2,117 units of AMGEN stock worth over $3,261,192 and over the last 4 years she sold AMGN stock worth over $1,395,062.

Ms Grygiel AMGN stock SEC Form 4 insiders trading

Ms has made over 4 trades of the AMGEN stock since 2021, according to the Form 4 filled with the SEC. Most recently she sold 2,117 units of AMGN stock worth $662,812 on 3 May 2024.

The largest trade she's ever made was exercising 2,500 units of AMGEN stock on 11 May 2021 worth over $406,500. On average, Ms trades about 242 units every 36 days since 2020. As of 3 May 2024 she still owns at least 9,883 units of AMGEN stock.

You can see the complete history of Ms Grygiel stock trades at the bottom of the page.





Ms. Nancy A. Grygiel biography

Nancy A. Grygiel is the Sr. VP of Worldwide Compliance & Bus. Ethics and Chief Compliance Officer at AMGEN.



How old is Ms Grygiel?

Ms Grygiel is 53, she's been the Sr. VP of Worldwide Compliance & Bus. Ethics and Chief Compliance Officer of AMGEN since . There are 21 older and 2 younger executives at AMGEN. The oldest executive at AMGEN Inc. is Fred Hassan, 74, who is the Independent Director.

What's Ms Grygiel's mailing address?

Nancy's mailing address filed with the SEC is ONE AMGEN CENTER DRIVE, , THOUSAND OAKS, CA, 91320.

Insiders trading at AMGEN

Over the last 22 years, insiders at AMGEN have traded over $219,663,137 worth of AMGEN stock and bought 8,904 units worth $919,219 . The most active insiders traders include Robert Eckert, Kevin W Sharer és Ellen Jamison Kullman. On average, AMGEN executives and independent directors trade stock every 35 days with the average trade being worth of $8,732,261. The most recent stock trade was executed by Nancy A. Grygiel on 3 May 2024, trading 2,117 units of AMGN stock currently worth $662,812.



What does AMGEN do?

Amgen Inc. is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. One of the worlds largest independent biotechnology companies, Amgen was established in Thousand Oaks, California, in 1980.



Complete history of Ms Grygiel stock trades at AMGEN

Az érdekelt
Trans.
Tranzakció
Teljes ár
Nancy A. Grygiel
SVP és CCO
Eladás $662,812
3 May 2024
Nancy A. Grygiel
SVP és CCO
Eladás $572,271
4 Dec 2023
Nancy A. Grygiel
SVP és CCO
Eladás $159,979
5 Nov 2022
Nancy A. Grygiel
SVP és CCO
Opció Gyakorlat $406,500
11 May 2021


AMGEN executives and stock owners

AMGEN executives and other stock owners filed with the SEC include: